FDA OKs aerosol spray to treat GI tract bleeding: 3 things to know

Wilson-Cook Medical on May 7 earned FDA clearance for its product Hemospray, which is designed to help control bleeding in the gastrointestinal tract.

Advertisement

Here are three things to know.

1. Hemospray is an aerosolized spray containing a mineral blend that is applied to the bleeding site in the upper or lower GI tract.

2. The spray, intended for use during endoscopic procedures, can cover large areas, such as ulcers or tumors.

3. During a clinical trial containing 228 patients, Hemospray stopped upper and lower GI bleeding in 95 percent of patients within five minutes of application.

More articles on supply chain:
Commissioner Dr. Scott Gottlieb says FDA is ‘actively developing’ regulatory framework for AI technologies
South Dakota hospital keeps dumping medical waste in city landfill despite fines
McKesson adds Medtronic exec as independent director: 4 takeaways

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

From fragmentation to operational flow: Solving the healthcare workforce puzzle

Tuesday, August 11
1:00 PM - 2:00 PM CDT

Presenters: Dr. Pat Hunt, QGendaAndrea Daugherty, MHA, CISSP, CHCIO, CDH-E, Arrowhead Regional Medical CenterElizabeth Lindsay-Wood, MBA, CHCIO, CDH-E, Moffitt Cancer CenterDeb Muro, El Camino HealthJohn Tejeda, D.H.A., MLS, MPAS, DFAAPA, LSSBB, FACHE, Vascular and Neuroscience Institute

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.